FDA PMA FDA Class 3 Approved 🇺🇸 United States

Aortic Valve, Prosthesis, Percutaneously Delivered

PMA: P130009 · Supplement: S062 · Decision Aug 19, 2016
Classifications
1
FEI Numbers
24
Registration Numbers
24

Basic Information

Device Name
Aortic Valve, Prosthesis, Percutaneously Delivered
Trade Name
EDWARDS SAPIEN XT TRANSCATHETER HEART VALVE
PMA Number
P130009
Supplement Number
S062
Device Class
FDA Class 3
Product Code
NPT
Generic Name
Aortic valve, prosthesis, percutaneously delivered
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
August 19, 2016
Date Received
July 1, 2016
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Postapproval Study Protocol
Expedited Review
N

Advisory Committee Statement

Approval for various changes to the post-approval study protocol for the continued follow-up of the IDE Nested Registry #3.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NPT Aortic Valve, Prosthesis, Percutaneously Delivered